Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in activity-based probes (ABPs) and affinity-based probes (AfBPs) for profiling of enzymes
Haixiao Fang, Bo Peng, Sing Yee Ong, et al.
Chemical Science (2021) Vol. 12, Iss. 24, pp. 8288-8310
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Current methods to analyze lysosome morphology, positioning, motility and function
Duarte C. Barral, Leopoldo Staiano, Cláudia G. Almeida, et al.
Traffic (2022) Vol. 23, Iss. 5, pp. 238-269
Open Access | Times Cited: 78
Sulfur(vi) fluorides as tools in biomolecular and medicinal chemistry
Sabrina N. Carneiro, Samuel R. Khasnavis, Jisun Lee, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 7, pp. 1356-1372
Open Access | Times Cited: 41
Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development
Guanghui Tang, Wei Wang, Chengjun Zhu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 12
The emergence of the C–H functionalization strategy in medicinal chemistry and drug discovery
Ranjan Jana, Hasina Mamataj Begam, Enakshi Dinda
Chemical Communications (2021) Vol. 57, Iss. 83, pp. 10842-10866
Closed Access | Times Cited: 84
Cell‐Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR‐ABL Kinase
Peng Chen, Jie Sun, Chengjun Zhu, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 26
Closed Access | Times Cited: 47
2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases
Peng Chen, Guanghui Tang, Chengjun Zhu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 3844-3849
Closed Access | Times Cited: 29
Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 26
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry
Rambabu Reddi, Adi Rogel, Ronen Gabizon, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 6, pp. 3346-3360
Open Access | Times Cited: 20
Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid
Qinghua Wang, Tingting Du, Zhi‐Hui Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4431-4442
Open Access | Times Cited: 6
Image-Based Phenotypic Profiling Enables Rapid and Accurate Assessment of EGFR-Activating Mutations in Tissues from Lung Cancer Patients
Qian Lei, Xinglong Zhou, Ying Li, et al.
Journal of the American Chemical Society (2025)
Closed Access
Chemical Proteomic Profiling Reveals Prostaglandin Termination Enzyme PTGR2 as a Key Molecular Target of Natural Coumarin Fraxetin
Songyao Kang, Zhiwei Cai, Yuqing Wang, et al.
Chemical Communications (2025)
Closed Access
Function and inhibition of the DNA repair enzyme SNM1A
Mark Berney, Steven Ferguson, Joanna F. McGouran
Bioorganic Chemistry (2025), pp. 108225-108225
Closed Access
Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain
Keliang Chen, Tao Wang, Yong Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 3, pp. 1326-1336
Open Access | Times Cited: 16
Glycosidase-targeting small molecules for biological and therapeutic applications
Yujun Kim, Hui Li, JooHee Choi, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 20, pp. 7036-7070
Closed Access | Times Cited: 15
Technologies for Direct Detection of Covalent Protein–Drug Adducts
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
The pharmacology and therapeutic role of cannabidiol in diabetes
Jin Sheng Zhang, Cong Lin, Sha Jin, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 14
Starting with screening strains to construct synthetic microbial communities (SynComs) for traditional food fermentation
Xinyi Jiang, Zheng Peng, Juan Zhang
Food Research International (2024) Vol. 190, pp. 114557-114557
Closed Access | Times Cited: 5
Cu-Catalyzed Azide–Alkyne–Thiol Reaction Forms Ubiquitous Background in Chemical Proteomic Studies
Andreas Wiest, Pavel Kielkowski
Journal of the American Chemical Society (2024) Vol. 146, Iss. 3, pp. 2151-2159
Open Access | Times Cited: 4
The Bis(monoacylglycero)-phosphate Hypothesis: From Lysosomal Function to Therapeutic Avenues
Uche N. Medoh, Monther Abu-Remaileh
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 447-469
Closed Access | Times Cited: 4
Proteomic Profiling of Antimalarial Plasmodione Using 3‐Benz(o)ylmenadione Affinity‐Based Probes
Ilaria Iacobucci, Vittoria Monaco, Agnès Hovasse, et al.
ChemBioChem (2024) Vol. 25, Iss. 15
Open Access | Times Cited: 4
Extremophiles in a changing world
Don A. Cowan, Sonja‐Verena Albers, Garabed Antranikian, et al.
Extremophiles (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 4
Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 23
Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4
Liquan Zhu, Shiqi Hu, Xiaoqiao Yan, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106461-106461
Closed Access | Times Cited: 13
Protein–protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies
Bobby Lucero, Karol R. Francisco, Lawrence J. Liu, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 474-488
Open Access | Times Cited: 13
Target Identification in Anti-Tuberculosis Drug Discovery
Rita Capela, Rita Félix, Marta Clariano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10482-10482
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top